chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Report completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose03/29/21 2nd dose04/16/2021 Diagnosed covid positive:09/02/21 Symptom onset:09/01/2021 Exposure: Symptoms:cough, fatigue,chills,runny nose,headache
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose01/31/21 2nd dose02/21/21 Diagnosed covid positive:09/03/21 Symptom onset:09/01/21 Exposure: Symptoms:cough fatigue,muscleaches,runny nose
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Asthenia, Brain natriuretic peptide increased, Chest pain, Decreased appetite
Clinical narrative: concerns of vaccine induced myocarditis. Noted to be less energetic, poor appetite, pale and sweaty appearing starting 3 days PTA. SOB and chest pain started 1 day PTA.  For the last two days he has had fevers (~100F) with generalized abdominal pain and diarrhea. A rash developed on his hands, chest, and legs, about 24 hours ago while he was febrile. The rash has persisted especially while febrile. ROS was otherwise negative; no vomiting, cough, loss of smell, etc. He has noticed improvement of symptoms with Ibuprofen. He received his first COVID-19 vaccine on 08/25/2021 (Pfizer). A classmate tested positive this week for COVID-19.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Hyperhidrosis, Pallor, Pyrexia
Clinical narrative: concerns of vaccine induced myocarditis. Noted to be less energetic, poor appetite, pale and sweaty appearing starting 3 days PTA. SOB and chest pain started 1 day PTA.  For the last two days he has had fevers (~100F) with generalized abdominal pain and diarrhea. A rash developed on his hands, chest, and legs, about 24 hours ago while he was febrile. The rash has persisted especially while febrile. ROS was otherwise negative; no vomiting, cough, loss of smell, etc. He has noticed improvement of symptoms with Ibuprofen. He received his first COVID-19 vaccine on 08/25/2021 (Pfizer). A classmate tested positive this week for COVID-19.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Troponin
Clinical narrative: concerns of vaccine induced myocarditis. Noted to be less energetic, poor appetite, pale and sweaty appearing starting 3 days PTA. SOB and chest pain started 1 day PTA.  For the last two days he has had fevers (~100F) with generalized abdominal pain and diarrhea. A rash developed on his hands, chest, and legs, about 24 hours ago while he was febrile. The rash has persisted especially while febrile. ROS was otherwise negative; no vomiting, cough, loss of smell, etc. He has noticed improvement of symptoms with Ibuprofen. He received his first COVID-19 vaccine on 08/25/2021 (Pfizer). A classmate tested positive this week for COVID-19.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive
Clinical narrative: VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose: 02/27/2021 2nd dose03/202/21 Diagnosed covid positive:09/03/21 Symptom onset: Exposure:travel Symptoms:asymptomatic
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Memory impairment
Clinical narrative: Memory issues - difficulty identifying, focusing, following thru; This spontaneous case was reported by a consumer and describes the occurrence of MEMORY IMPAIRMENT (Memory issues - difficulty identifying, focusing, following thru) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Food intolerance NOS (Food sensitivities).   On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Jun-2021, the patient experienced MEMORY IMPAIRMENT (Memory issues - difficulty identifying, focusing, following thru). At the time of the report, MEMORY IMPAIRMENT (Memory issues - difficulty identifying, focusing, following thru) outcome was unknown.            No concomitant medications were reported.  No treatment information was reported.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Dizziness; Dizziness and Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and VERTIGO (Dizziness and Vertigo) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 80777-0273-15) for COVID-19 vaccination.     Concurrent medical conditions included Celiac disease, Allergy to metals (Allergy to nickel ,latex), Drug allergy (Allergy to codeine related drugs.), Drug allergy (armodafinil) and Drug allergy (lisinopril.).   On 31-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Sep-2021, the patient experienced DIZZINESS (Dizziness) and VERTIGO (Dizziness and Vertigo). At the time of the report, DIZZINESS (Dizziness) and VERTIGO (Dizziness and Vertigo) had not resolved. Not Provided          No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Generalised tonic-clonic seizure, Urinary tract infection
Clinical narrative: Grand Mal Seizure; Urinary Tract Infection; This spontaneous case was reported by a consumer and describes the occurrence of GENERALISED TONIC-CLONIC SEIZURE (Grand Mal Seizure) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040c21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Aug-2021, the patient experienced GENERALISED TONIC-CLONIC SEIZURE (Grand Mal Seizure) (seriousness criterion medically significant) and URINARY TRACT INFECTION (Urinary Tract Infection). At the time of the report, GENERALISED TONIC-CLONIC SEIZURE (Grand Mal Seizure) and URINARY TRACT INFECTION (Urinary Tract Infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment medication were provided No Concomitant medication were provided Unknown lab tests done resulted in UTI (Urinary tract infection) Company Comment : Based on the current available information which state that the patient does not have any prior history of seizures and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded. Therefore, causality for the event of generalised tonic-clonic seizure  of is possibly related. Due to lack of any plausible mechanism connecting mRNA-1273 and occurrence of urinary tract infection, causality for the event of urinary tract infection is assessed as unlikely related to mRNA-1273.   Most recent FOLLOW-UP information incorporated above includes: On 04-Sep-2021: Follow up received on 04-SEP-2021 contains No new information. However, updated reporter type to Non-Health Professional, missed in earlier step.; Sender's Comments: Based on the current available information which state that the patient does not have any prior history of seizures and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded. Therefore, causality for the event of generalised tonic-clonic seizure  of is possibly related. Due to lack of any plausible mechanism connecting mRNA-1273 and occurrence of urinary tract infection, causality for the event of urinary tract infection is assessed as unlikely related to mRNA-1273.
Sex: U
Vaccine: MMRV
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional adverse event reported; Caller reports an expired dose of PROQUAD was administered to a patient yesterday; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. Information regarding the patient's concomitant therapies, current conditions, medical history and historical drug was not provided.   On 01-SEP-2021, the patient was vaccinated with an expired dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (dosage regimen was not reported) lot number T007395 (rHA) and expiration date 29-AUG-2021, administered as prophylaxis.  No additional adverse events were reported.
Sex: U
Vaccine: MMR
Symptoms: Incomplete course of vaccination, Viral titre
Clinical narrative: The patient did not receive additional dose of M-M-R II after titer testing; The patient took a titer for measles to prove immunity instead, rather than use the MMR vaccine unnecessarily; This spontaneous report was received from a patient of unknown age and gender referring to himself/herself. The patient's concomitant medication, pertinent medical history and drug reactions/ allergies were not reported.      On an unknown date, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) (dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis. Additionally, the patient took a titer for measles to prove immunity instead, rather than get the second dose of the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) vaccine unnecessarily.
Sex: M
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: had antibody titers done and he does not have detectable varicella antibodies; This spontaneous report was received from an employee referring to himself, a male patient of unknown age. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  On 24-AUG-1998 and 29-NOV-2007, the patient was vaccinated with two doses of varicella vaccine, unknown if it was varicella virus vaccine live (oka/merck) (VARIVAX) (strength, route, lot# and expiration date were not reported) for prophylaxis. The doses were 9 years apart.  On an unknown date (reported as recently), the patient had antibody titers done and he did not have detectable varicella antibodies and was going to get a booster vaccine (antibody test negative). The outcome of antibody test negative was not resolved.  The causality assessment between antibody test negative and varicella virus vaccine live (oka/merck) (VARIVAX) was not reported.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Allergy to arthropod bite, Allergy to arthropod sting, Anxiety, Gout, Herpes zoster
Clinical narrative: a little tale tale sign is the grey/ on the face left a grey shadowing; has reactions to bee stings; anxiety; insect bites are worse and last longer/  mosquito bites last longer; gout; shingles/chicken pox/ since she had the reaction to the singles vaccine; shingles/chicken pox/ since she had the reaction to the singles vaccine; she had a rash that was torpedo shaped on almost her entire upper arm; This spontaneous report was received from a 70 years old female patient referring to herself. Concomitant products: no medications were relevant. She didn't take many medications back then and still didn't.  In approximately 2011 (reported as about 10 years ago/ between 8 to 10 years ago), the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, route, lot# and expiration date were not reported) in the left arm for prophylaxis.         The patient had reactions to the vaccine. After she received the shingles vaccine she had a rash that was torpedo shaped on almost her entire upper arm that lasted for 10 days (also reported would last 7 to 10 days) and then broke out into shingles/chicken pox that had 5 or 6 with two on her abdomen and some on her face but they did not itch or get pustular. When it went away it left a gray shadowing area on her face but not on her abdomen (skin discolouration). She would have looked like a camouflaged person. The patient did not have an allergic reaction to an ingredient but where she received it, said it was possible to get a few chickenpox/shingles from the vaccine. After the incidence with the shingles vaccine she now carried epi pens because she had reactions to bee stings and it was Iike anxiety so the doctor gave her a epi pen to carry in case she went into anaphylactic shock. The patient said that also insect bites were worse and last longer and mosquito bites last longer and stated she didn't know if the vaccine attributed to a change in her system. She also read something about vaccines and gout and she recently had gout. The outcome of shingles/chickenpox was unknown. She had recovered rash completely. Outcome of other events was unknown.  The causality between zoster vaccine live (ZOSTAVAX) and shingles/chickenpox, rash, skin discolouration was considered as related. The causality between zoster vaccine live (ZOSTAVAX) and other events was unknown.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: a little tale tale sign is the grey/ on the face left a grey shadowing; has reactions to bee stings; anxiety; insect bites are worse and last longer/  mosquito bites last longer; gout; shingles/chicken pox/ since she had the reaction to the singles vaccine; shingles/chicken pox/ since she had the reaction to the singles vaccine; she had a rash that was torpedo shaped on almost her entire upper arm; This spontaneous report was received from a 70 years old female patient referring to herself. Concomitant products: no medications were relevant. She didn't take many medications back then and still didn't.  In approximately 2011 (reported as about 10 years ago/ between 8 to 10 years ago), the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, route, lot# and expiration date were not reported) in the left arm for prophylaxis.         The patient had reactions to the vaccine. After she received the shingles vaccine she had a rash that was torpedo shaped on almost her entire upper arm that lasted for 10 days (also reported would last 7 to 10 days) and then broke out into shingles/chicken pox that had 5 or 6 with two on her abdomen and some on her face but they did not itch or get pustular. When it went away it left a gray shadowing area on her face but not on her abdomen (skin discolouration). She would have looked like a camouflaged person. The patient did not have an allergic reaction to an ingredient but where she received it, said it was possible to get a few chickenpox/shingles from the vaccine. After the incidence with the shingles vaccine she now carried epi pens because she had reactions to bee stings and it was Iike anxiety so the doctor gave her a epi pen to carry in case she went into anaphylactic shock. The patient said that also insect bites were worse and last longer and mosquito bites last longer and stated she didn't know if the vaccine attributed to a change in her system. She also read something about vaccines and gout and she recently had gout. The outcome of shingles/chickenpox was unknown. She had recovered rash completely. Outcome of other events was unknown.  The causality between zoster vaccine live (ZOSTAVAX) and shingles/chickenpox, rash, skin discolouration was considered as related. The causality between zoster vaccine live (ZOSTAVAX) and other events was unknown.
Sex: U
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: rash around torso; This case was reported by a consumer via (Shingrix GSK chatbot) interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided are as follows: The case was reported by patient for himself/herself. The age at vaccination was not reported. The patient received a dose of Shingrix shot and had rash around torso. The patient asked if you get a rash around your torso after 1st dose shot are you allergic to the vaccine. The patient asked should he/she get the 2nd dose. The follow up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Musculoskeletal chest pain, Musculoskeletal pain, Rash
Clinical narrative: Shingles rash; intense pain on  left rib cage; intense pain on left shoulder blade; Rash; This case was reported by a consumer and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th August 2021, the patient received the 1st dose of Shingrix. On 5th September 2021, 7 days after receiving Shingrix, the patient experienced shingles, rib pain, shoulder blade pain and rash. On an unknown date, the outcome of the shingles, rib pain, shoulder blade pain and rash were not recovered/not resolved.   It was unknown if the reporter considered the shingles, rib pain, shoulder blade pain and rash to be related to Shingrix.  Additional details were provided are as follows: The case was reported by patient for himself/herself. The age at vaccination was not reported. The patient received a dose of Shingrix and had developed a Shingles rash and intense pain on his/her left rib cage and left shoulder blade. The reporter consented to follow-up. The reporter requested a call from GlaxoSmithKline in order to have his/her questions answered and concerns hopefully eased.
Sex: U
Vaccine: VARZOS
Symptoms: Feeling abnormal
Clinical narrative: Felt worse than the flu; This case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received on an unknown date, which was fine).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feeling bad. On an unknown date, the outcome of the feeling bad were unknown.   It was unknown if the reporter considered the feeling bad to be related to Shingles vaccine.  Additional details provided were as follows: The case was reported by the patient for himself/herself. The age at vaccination was not reported. The patient got the shots, first one was fine but after the second shot, the patient experienced every side effect.  The patient further stated that that was not fun at all and felt worse than the flu. Follow-up would not be possible as no contact details available. The case was reported by case US2021AMR190831, reported by same reporter for same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR190831:Same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Burning sensation, Pain in extremity
Clinical narrative: The first shot hurt; my arm "burned"; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain and burning sensation. On an unknown date, the outcome of the pain and burning sensation were recovered/resolved.   It was unknown if the reporter considered the pain and burning sensation to be related to Shingles vaccine.  Additional details were provided as follows: This case was self-reported by the patient. The age at vaccination was not reported. The patient received Shingles vaccine and his/her arm hurt and burned for a week or more then was fine. The patient had no issue since, about 5 years. For the tolerance of 2nd dose, refer case US2021AMR190661.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR190661:same reporter
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Chest pain, Dizziness, Palpitations
Clinical narrative: Patient called Public Health Center 9/13/21 to inquire where she can get assistance for a vaccine related adverse event as she is uninsured. She was given the web site.  She reports feeling heart palpations starting the day after and ongoing on and off after receiving 1st Moderna vaccine on Aug 10th from local pharmacy.  She reports having this on and off for extended time but attributed it to anxiety.  After her 2nd dose, Sept 7th from the same Pharmacy, the next day she reported having chest pain on and off ongoing. Then she began feeling dizziness. At this point she realized that this was not within normal for her.  She said that?s when she realized that her symptoms coincided with receiving the vaccine.  She is uninsured 30yo mother of breast feeling infant.  She inquired where to get services. She was directed to Qualified health care clinic. She was read the data safety sheet and instructed to get immediate medical care if she began feeling chest pain, shortness of breath and heart palpations. At the time of this call she was not experiencing symptoms but due to their coming and going nature she thought it best to be evaluated.  I informed her I would be making a VAERS report.
Age: 49.0
Sex: M
Vaccine: UNK
Symptoms: Cough, Respiratory tract congestion, SARS-CoV-2 test negative
Clinical narrative: Incessant Cough, congestion- treated with antibiotic - cough still ongoing 3 weeks later.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Atrial fibrillation, Echocardiogram normal, Electrocardiogram normal, Intensive care
Clinical narrative: Atrial fibrillation.  Went to emergency room was admitted and spent two days in intensive care until it was brought back to normal.  Was prescribed amiodarone and eliquis and episodes subsequent episodes diminished and have not had one since May 13, 2021.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Culture, Urinary tract infection, Urine analysis
Clinical narrative: Developed a Urinary Track Infection (UTI)  25 days after first vaccine.  Last UTI prior to that was in July 2020, Physician recommended to get the second vaccine on 4/1/21 and developed a second UTI on 4/17/21, again on 5/3/21 and 7/7/21.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Shingles; This case was reported by a consumer via social media interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 weeks after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient. The age at vaccination was not reported. The patient took the shot and about two weeks later got shingles.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Catheterisation cardiac, Laboratory test
Clinical narrative: Patient had a nonST Myocardial infarction.  The Catheterization done while in the hospital showed the affected vessel open.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Rash erythematous
Clinical narrative: Very large red skin rash around the injection sight.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Balance disorder, Condition aggravated, Dermatitis, Disturbance in attention
Clinical narrative: I have developed full-body dermatitis and peeling skin- my brain is fuzzy and it is hard to focus - I am extremely fatigued, tire easily, and run out of breath quickly - I have blurry vision and my hearing is affected - I am very shaky, my balance is off - my elbows/joints are painful and I get headaches and am severely stressed.  I do not recall noticing a huge reaction after the first shot and I am not clear exactly what minute these negative effects started - but they did become very pronounced after the second shot and are getting worse, not better. In April, I saw a dermatologist for a small amount of dermatitis, but it went away completely.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Feeling abnormal, Headache, Hypoacusis
Clinical narrative: I have developed full-body dermatitis and peeling skin- my brain is fuzzy and it is hard to focus - I am extremely fatigued, tire easily, and run out of breath quickly - I have blurry vision and my hearing is affected - I am very shaky, my balance is off - my elbows/joints are painful and I get headaches and am severely stressed.  I do not recall noticing a huge reaction after the first shot and I am not clear exactly what minute these negative effects started - but they did become very pronounced after the second shot and are getting worse, not better. In April, I saw a dermatologist for a small amount of dermatitis, but it went away completely.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Nervousness, Skin exfoliation, Vision blurred
Clinical narrative: I have developed full-body dermatitis and peeling skin- my brain is fuzzy and it is hard to focus - I am extremely fatigued, tire easily, and run out of breath quickly - I have blurry vision and my hearing is affected - I am very shaky, my balance is off - my elbows/joints are painful and I get headaches and am severely stressed.  I do not recall noticing a huge reaction after the first shot and I am not clear exactly what minute these negative effects started - but they did become very pronounced after the second shot and are getting worse, not better. In April, I saw a dermatologist for a small amount of dermatitis, but it went away completely.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Numbness and tingling to the hand and arm of vaccinated arm, 2nd dose COVID vaccination, numbness and tingling has lasted 10 days so far with no improvement.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Blood iron normal, Blood test normal, Condition aggravated
Clinical narrative: Fever, body aches, weakness, dizziness, exhaustion, headaches, loss of appetite - gradually improving over 2-3 week period. However, I continue to experience exhaustion, weakness, dizziness and brain fog most days at varying degrees. My acid reflux has become much worse and I experience more anxiety now. A general feeling of malaise.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Fatigue, Feeling abnormal, Gastrooesophageal reflux disease
Clinical narrative: Fever, body aches, weakness, dizziness, exhaustion, headaches, loss of appetite - gradually improving over 2-3 week period. However, I continue to experience exhaustion, weakness, dizziness and brain fog most days at varying degrees. My acid reflux has become much worse and I experience more anxiety now. A general feeling of malaise.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise, Pain, Pyrexia, Thyroid function test normal
Clinical narrative: Fever, body aches, weakness, dizziness, exhaustion, headaches, loss of appetite - gradually improving over 2-3 week period. However, I continue to experience exhaustion, weakness, dizziness and brain fog most days at varying degrees. My acid reflux has become much worse and I experience more anxiety now. A general feeling of malaise.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate abnormal
Clinical narrative: Heart rate range from 178-200 all night.  Ended up in ER.  Referral to cardiologist.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Fall, Headache, Nausea
Clinical narrative: Patient became dizzy lightheaded, fell over, N&V, Headache pain 8/10. BP 179/102, HR 93, SaO2 100 %. Unable to sit up. Began to complain of chest pain 3/10 lt arm pain, called 911 for transport
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Sitting disability, Vomiting
Clinical narrative: Patient became dizzy lightheaded, fell over, N&V, Headache pain 8/10. BP 179/102, HR 93, SaO2 100 %. Unable to sit up. Began to complain of chest pain 3/10 lt arm pain, called 911 for transport
Sex: U
Vaccine: VARZOS
Symptoms: Hypersensitivity
Clinical narrative: allergic reaction; This case was reported by a consumer via interactive digital media and described the occurrence of allergic reaction in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine, the patient experienced allergic reaction. On an unknown date, the outcome of the allergic reaction was unknown.   It was unknown if the reporter considered the allergic reaction to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient himself/herself. Age at vaccination was not reported. The patient received 1st dose last year and did not went back for 2nd one because he/she had a allergic reaction. The follow up could not be possible as no contact details were available.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Angiotensin converting enzyme, Antineutrophil cytoplasmic antibody negative, Back pain, Bacterial test negative, Borrelia test negative
Clinical narrative: Patient presented to a local emergency department with fever, intermittent chills, chest and back pain. The pain was worse when lying flat and relieved by leaning forward. Patient reported the onset of symptoms around two weeks after he received his second dose of COVID-19 vaccine .An initial laboratory workup showed mild leukocytosis with white blood cell (WBC) count of  15,000/ cells/mm3, and elevated inflammatory markers of C reactive protein (CRP) was 247?mg/L (normal <5?mg/L). . CT chest with IV contrast ordered to rule out pulmonary embolism which revealed new pericardial effusion. Transthoracic echocardiography showed a large circumferential pericardial effusion without tamponade physiology .Pericardiocentesis and drainage were performed, draining 560 mL of bloody effusion in total. The pericardial fluid was sent for culture, cell analysis, and cytology. Both bacterial and fungal cultures remained negative. A16S rRNA gene amplification and sequencing test was also negative. Cytological examination did not show malignant cells.An intensive work-up for a cause was performed. A computed tomography scan of chest, abdomen and pelvis ruled out tumor masses. Autoimmunity study, quantiferon, antineutrophil cytoplasmic antibody (ANCA), serum angiotensin converting enzyme (ACE) and Lyme serology were all negative. Antibody test for coxcackievirus, CMV, EBV, B19, HHV6, HIV, HCV were negative.Patient was doing well for a week after discharge from the hospital, until he started to have back pain, intermittent fever and chills again. He was admitted again to the hospital and repeated thoracic echocardiogram showed a small precordial effusion. Treatment with ibuprofen  and colchicine started. On a 4-week follow-up, our patient reported a resolution of chest pain. Both colchicine and ibuprofen were discontinued.. Cardiovascular magnetic resonance imaging (CMR) was conducted to exclude possible infiltrative etiology of myopericarditis. The exam revealed no signs of active inflammation  but did show a small area of epicardial enhancement characteristic of prior myocarditis
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, Cardiac imaging procedure normal, Chest pain, Chills, Computerised tomogram abdomen normal
Clinical narrative: Patient presented to a local emergency department with fever, intermittent chills, chest and back pain. The pain was worse when lying flat and relieved by leaning forward. Patient reported the onset of symptoms around two weeks after he received his second dose of COVID-19 vaccine .An initial laboratory workup showed mild leukocytosis with white blood cell (WBC) count of  15,000/ cells/mm3, and elevated inflammatory markers of C reactive protein (CRP) was 247?mg/L (normal <5?mg/L). . CT chest with IV contrast ordered to rule out pulmonary embolism which revealed new pericardial effusion. Transthoracic echocardiography showed a large circumferential pericardial effusion without tamponade physiology .Pericardiocentesis and drainage were performed, draining 560 mL of bloody effusion in total. The pericardial fluid was sent for culture, cell analysis, and cytology. Both bacterial and fungal cultures remained negative. A16S rRNA gene amplification and sequencing test was also negative. Cytological examination did not show malignant cells.An intensive work-up for a cause was performed. A computed tomography scan of chest, abdomen and pelvis ruled out tumor masses. Autoimmunity study, quantiferon, antineutrophil cytoplasmic antibody (ANCA), serum angiotensin converting enzyme (ACE) and Lyme serology were all negative. Antibody test for coxcackievirus, CMV, EBV, B19, HHV6, HIV, HCV were negative.Patient was doing well for a week after discharge from the hospital, until he started to have back pain, intermittent fever and chills again. He was admitted again to the hospital and repeated thoracic echocardiogram showed a small precordial effusion. Treatment with ibuprofen  and colchicine started. On a 4-week follow-up, our patient reported a resolution of chest pain. Both colchicine and ibuprofen were discontinued.. Cardiovascular magnetic resonance imaging (CMR) was conducted to exclude possible infiltrative etiology of myopericarditis. The exam revealed no signs of active inflammation  but did show a small area of epicardial enhancement characteristic of prior myocarditis
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Coxiella test, Culture, Cytology, Cytomegalovirus test negative
Clinical narrative: Patient presented to a local emergency department with fever, intermittent chills, chest and back pain. The pain was worse when lying flat and relieved by leaning forward. Patient reported the onset of symptoms around two weeks after he received his second dose of COVID-19 vaccine .An initial laboratory workup showed mild leukocytosis with white blood cell (WBC) count of  15,000/ cells/mm3, and elevated inflammatory markers of C reactive protein (CRP) was 247?mg/L (normal <5?mg/L). . CT chest with IV contrast ordered to rule out pulmonary embolism which revealed new pericardial effusion. Transthoracic echocardiography showed a large circumferential pericardial effusion without tamponade physiology .Pericardiocentesis and drainage were performed, draining 560 mL of bloody effusion in total. The pericardial fluid was sent for culture, cell analysis, and cytology. Both bacterial and fungal cultures remained negative. A16S rRNA gene amplification and sequencing test was also negative. Cytological examination did not show malignant cells.An intensive work-up for a cause was performed. A computed tomography scan of chest, abdomen and pelvis ruled out tumor masses. Autoimmunity study, quantiferon, antineutrophil cytoplasmic antibody (ANCA), serum angiotensin converting enzyme (ACE) and Lyme serology were all negative. Antibody test for coxcackievirus, CMV, EBV, B19, HHV6, HIV, HCV were negative.Patient was doing well for a week after discharge from the hospital, until he started to have back pain, intermittent fever and chills again. He was admitted again to the hospital and repeated thoracic echocardiogram showed a small precordial effusion. Treatment with ibuprofen  and colchicine started. On a 4-week follow-up, our patient reported a resolution of chest pain. Both colchicine and ibuprofen were discontinued.. Cardiovascular magnetic resonance imaging (CMR) was conducted to exclude possible infiltrative etiology of myopericarditis. The exam revealed no signs of active inflammation  but did show a small area of epicardial enhancement characteristic of prior myocarditis
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram, Epstein-Barr virus antibody negative, Fungal test, Gene mutation identification test negative, HIV antibody negative
Clinical narrative: Patient presented to a local emergency department with fever, intermittent chills, chest and back pain. The pain was worse when lying flat and relieved by leaning forward. Patient reported the onset of symptoms around two weeks after he received his second dose of COVID-19 vaccine .An initial laboratory workup showed mild leukocytosis with white blood cell (WBC) count of  15,000/ cells/mm3, and elevated inflammatory markers of C reactive protein (CRP) was 247?mg/L (normal <5?mg/L). . CT chest with IV contrast ordered to rule out pulmonary embolism which revealed new pericardial effusion. Transthoracic echocardiography showed a large circumferential pericardial effusion without tamponade physiology .Pericardiocentesis and drainage were performed, draining 560 mL of bloody effusion in total. The pericardial fluid was sent for culture, cell analysis, and cytology. Both bacterial and fungal cultures remained negative. A16S rRNA gene amplification and sequencing test was also negative. Cytological examination did not show malignant cells.An intensive work-up for a cause was performed. A computed tomography scan of chest, abdomen and pelvis ruled out tumor masses. Autoimmunity study, quantiferon, antineutrophil cytoplasmic antibody (ANCA), serum angiotensin converting enzyme (ACE) and Lyme serology were all negative. Antibody test for coxcackievirus, CMV, EBV, B19, HHV6, HIV, HCV were negative.Patient was doing well for a week after discharge from the hospital, until he started to have back pain, intermittent fever and chills again. He was admitted again to the hospital and repeated thoracic echocardiogram showed a small precordial effusion. Treatment with ibuprofen  and colchicine started. On a 4-week follow-up, our patient reported a resolution of chest pain. Both colchicine and ibuprofen were discontinued.. Cardiovascular magnetic resonance imaging (CMR) was conducted to exclude possible infiltrative etiology of myopericarditis. The exam revealed no signs of active inflammation  but did show a small area of epicardial enhancement characteristic of prior myocarditis
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Hepatitis C virus test, Human herpes virus 6 serology negative, Inflammatory marker increased, Leukocytosis, Pain
Clinical narrative: Patient presented to a local emergency department with fever, intermittent chills, chest and back pain. The pain was worse when lying flat and relieved by leaning forward. Patient reported the onset of symptoms around two weeks after he received his second dose of COVID-19 vaccine .An initial laboratory workup showed mild leukocytosis with white blood cell (WBC) count of  15,000/ cells/mm3, and elevated inflammatory markers of C reactive protein (CRP) was 247?mg/L (normal <5?mg/L). . CT chest with IV contrast ordered to rule out pulmonary embolism which revealed new pericardial effusion. Transthoracic echocardiography showed a large circumferential pericardial effusion without tamponade physiology .Pericardiocentesis and drainage were performed, draining 560 mL of bloody effusion in total. The pericardial fluid was sent for culture, cell analysis, and cytology. Both bacterial and fungal cultures remained negative. A16S rRNA gene amplification and sequencing test was also negative. Cytological examination did not show malignant cells.An intensive work-up for a cause was performed. A computed tomography scan of chest, abdomen and pelvis ruled out tumor masses. Autoimmunity study, quantiferon, antineutrophil cytoplasmic antibody (ANCA), serum angiotensin converting enzyme (ACE) and Lyme serology were all negative. Antibody test for coxcackievirus, CMV, EBV, B19, HHV6, HIV, HCV were negative.Patient was doing well for a week after discharge from the hospital, until he started to have back pain, intermittent fever and chills again. He was admitted again to the hospital and repeated thoracic echocardiogram showed a small precordial effusion. Treatment with ibuprofen  and colchicine started. On a 4-week follow-up, our patient reported a resolution of chest pain. Both colchicine and ibuprofen were discontinued.. Cardiovascular magnetic resonance imaging (CMR) was conducted to exclude possible infiltrative etiology of myopericarditis. The exam revealed no signs of active inflammation  but did show a small area of epicardial enhancement characteristic of prior myocarditis
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Parvovirus B19 test negative, Pericardial drainage, Pericardial effusion, Pericardial haemorrhage, Pyrexia
Clinical narrative: Patient presented to a local emergency department with fever, intermittent chills, chest and back pain. The pain was worse when lying flat and relieved by leaning forward. Patient reported the onset of symptoms around two weeks after he received his second dose of COVID-19 vaccine .An initial laboratory workup showed mild leukocytosis with white blood cell (WBC) count of  15,000/ cells/mm3, and elevated inflammatory markers of C reactive protein (CRP) was 247?mg/L (normal <5?mg/L). . CT chest with IV contrast ordered to rule out pulmonary embolism which revealed new pericardial effusion. Transthoracic echocardiography showed a large circumferential pericardial effusion without tamponade physiology .Pericardiocentesis and drainage were performed, draining 560 mL of bloody effusion in total. The pericardial fluid was sent for culture, cell analysis, and cytology. Both bacterial and fungal cultures remained negative. A16S rRNA gene amplification and sequencing test was also negative. Cytological examination did not show malignant cells.An intensive work-up for a cause was performed. A computed tomography scan of chest, abdomen and pelvis ruled out tumor masses. Autoimmunity study, quantiferon, antineutrophil cytoplasmic antibody (ANCA), serum angiotensin converting enzyme (ACE) and Lyme serology were all negative. Antibody test for coxcackievirus, CMV, EBV, B19, HHV6, HIV, HCV were negative.Patient was doing well for a week after discharge from the hospital, until he started to have back pain, intermittent fever and chills again. He was admitted again to the hospital and repeated thoracic echocardiogram showed a small precordial effusion. Treatment with ibuprofen  and colchicine started. On a 4-week follow-up, our patient reported a resolution of chest pain. Both colchicine and ibuprofen were discontinued.. Cardiovascular magnetic resonance imaging (CMR) was conducted to exclude possible infiltrative etiology of myopericarditis. The exam revealed no signs of active inflammation  but did show a small area of epicardial enhancement characteristic of prior myocarditis
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Patient presented to a local emergency department with fever, intermittent chills, chest and back pain. The pain was worse when lying flat and relieved by leaning forward. Patient reported the onset of symptoms around two weeks after he received his second dose of COVID-19 vaccine .An initial laboratory workup showed mild leukocytosis with white blood cell (WBC) count of  15,000/ cells/mm3, and elevated inflammatory markers of C reactive protein (CRP) was 247?mg/L (normal <5?mg/L). . CT chest with IV contrast ordered to rule out pulmonary embolism which revealed new pericardial effusion. Transthoracic echocardiography showed a large circumferential pericardial effusion without tamponade physiology .Pericardiocentesis and drainage were performed, draining 560 mL of bloody effusion in total. The pericardial fluid was sent for culture, cell analysis, and cytology. Both bacterial and fungal cultures remained negative. A16S rRNA gene amplification and sequencing test was also negative. Cytological examination did not show malignant cells.An intensive work-up for a cause was performed. A computed tomography scan of chest, abdomen and pelvis ruled out tumor masses. Autoimmunity study, quantiferon, antineutrophil cytoplasmic antibody (ANCA), serum angiotensin converting enzyme (ACE) and Lyme serology were all negative. Antibody test for coxcackievirus, CMV, EBV, B19, HHV6, HIV, HCV were negative.Patient was doing well for a week after discharge from the hospital, until he started to have back pain, intermittent fever and chills again. He was admitted again to the hospital and repeated thoracic echocardiogram showed a small precordial effusion. Treatment with ibuprofen  and colchicine started. On a 4-week follow-up, our patient reported a resolution of chest pain. Both colchicine and ibuprofen were discontinued.. Cardiovascular magnetic resonance imaging (CMR) was conducted to exclude possible infiltrative etiology of myopericarditis. The exam revealed no signs of active inflammation  but did show a small area of epicardial enhancement characteristic of prior myocarditis
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy endometrium normal, Smear cervix, Ultrasound scan, Vaginal haemorrhage, Vaginal odour
Clinical narrative: 01/15/2021 - Smelled Metallic oder from vagina all day when I went to bathroom 01/16/2021 - Started to spot bleed 01/23/2021- Started bleeding all the time 02/22/2021 - Made an appointment with OB/GYN for March 1, 2021 03/01/2021 - Stopped Bleeding 05/16/2021 - Started Bleeding 06/05/2021 - Stopped Bleeding 06/15/2021 - Started Bleeding 06/25/2021 - Stopped Bleeding 07/03/2021 - Started Bleeding 07/07/2021 - Stopped Bleeding 07/16/2021 - Started Bleeding 07/21/2021 - Stopped Bleeding 08/17/2021 - Started Bleeding after Dr  did Endometruim Biopsy 09/01/2021 - Stopped Bleeding 09/05/2021 - Started Bleeding 08/23/2021 - Dr told me that legally he can not say that my bleeding is from the Covid 19 Vaccination Shot, but it more than likely is the cause of it.  He said , he has heard of many other women has also experiences these issues.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Decreased appetite, Dizziness, Fatigue, Hyperhidrosis
Clinical narrative: Woke up at 2am with sweating followed by vomiting, fever of 101F, joint/ muscle pain, lightheadedness.  Later the next day lymphadenitis in left axilla (same arm vx was given) fatigue, general malaise, inappetance, persistent fever.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenitis, Malaise, Myalgia, Pyrexia, Vomiting
Clinical narrative: Woke up at 2am with sweating followed by vomiting, fever of 101F, joint/ muscle pain, lightheadedness.  Later the next day lymphadenitis in left axilla (same arm vx was given) fatigue, general malaise, inappetance, persistent fever.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Cold sweat, Dizziness, Feeling hot, Headache
Clinical narrative: Excruciating headaches, blurry vision, face & tongue swelling, dizziness, severe stomach cramping, hot & cold sweats, nasuea.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Swelling face, Swollen tongue, Vision blurred
Clinical narrative: Excruciating headaches, blurry vision, face & tongue swelling, dizziness, severe stomach cramping, hot & cold sweats, nasuea.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Patient received severe swelling in her left arm 2 days after second dose.  She treated the adverse reaction with Claritin, Advil, Hydrocortisone for 2 days and it finally went away.  She also received a similar reaction with the first vaccine but not as severe and wide-spread.